Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q414462> ?p ?o }
Showing triples 1 to 67 of
67
with 100 triples per page.
- Q414462 subject Q7334131.
- Q414462 subject Q7486806.
- Q414462 subject Q8256055.
- Q414462 subject Q8312632.
- Q414462 subject Q8808701.
- Q414462 subject Q8965786.
- Q414462 abstract "Apixaban, sold under the tradename Eliquis, is a anticoagulant for the treatment of venous thromboembolic events. It is taken by mouth. It is a direct factor Xa inhibitor.Apixaban was approved in Europe in 2012. It was approved in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is being developed in a joint venture by Pfizer and Bristol-Myers Squibb.".
- Q414462 atcPrefix "B01".
- Q414462 atcSuffix "AF02".
- Q414462 casNumber "503612-47-3".
- Q414462 drugbank "DB07828".
- Q414462 fdaUniiCode "3Z9Y7UWC1J".
- Q414462 iupacName "1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide".
- Q414462 pubchem "10182969".
- Q414462 thumbnail Apixaban.svg?width=300.
- Q414462 wikiPageWikiLink Q101026.
- Q414462 wikiPageWikiLink Q12202.
- Q414462 wikiPageWikiLink Q12206.
- Q414462 wikiPageWikiLink Q1368197.
- Q414462 wikiPageWikiLink Q14864419.
- Q414462 wikiPageWikiLink Q14865111.
- Q414462 wikiPageWikiLink Q14890102.
- Q414462 wikiPageWikiLink Q1762339.
- Q414462 wikiPageWikiLink Q17912018.
- Q414462 wikiPageWikiLink Q181754.
- Q414462 wikiPageWikiLink Q188724.
- Q414462 wikiPageWikiLink Q206921.
- Q414462 wikiPageWikiLink Q21011234.
- Q414462 wikiPageWikiLink Q215118.
- Q414462 wikiPageWikiLink Q220570.
- Q414462 wikiPageWikiLink Q2273909.
- Q414462 wikiPageWikiLink Q266423.
- Q414462 wikiPageWikiLink Q27205.
- Q414462 wikiPageWikiLink Q2751330.
- Q414462 wikiPageWikiLink Q275466.
- Q414462 wikiPageWikiLink Q334477.
- Q414462 wikiPageWikiLink Q3425168.
- Q414462 wikiPageWikiLink Q419345.
- Q414462 wikiPageWikiLink Q420262.
- Q414462 wikiPageWikiLink Q468787.
- Q414462 wikiPageWikiLink Q487937.
- Q414462 wikiPageWikiLink Q652297.
- Q414462 wikiPageWikiLink Q65979.
- Q414462 wikiPageWikiLink Q7334131.
- Q414462 wikiPageWikiLink Q7486806.
- Q414462 wikiPageWikiLink Q815819.
- Q414462 wikiPageWikiLink Q8256055.
- Q414462 wikiPageWikiLink Q8312632.
- Q414462 wikiPageWikiLink Q8808701.
- Q414462 wikiPageWikiLink Q8965786.
- Q414462 wikiPageWikiLink Q906280.
- Q414462 wikiPageWikiLink Q9377.
- Q414462 atcPrefix "B01".
- Q414462 atcSuffix "AF02".
- Q414462 casNumber "503612".
- Q414462 drugbank "DB07828".
- Q414462 iupacName "1".
- Q414462 pubchem "10182969".
- Q414462 unii "3".
- Q414462 type ChemicalSubstance.
- Q414462 type Drug.
- Q414462 type ChemicalObject.
- Q414462 type Thing.
- Q414462 type Q8386.
- Q414462 comment "Apixaban, sold under the tradename Eliquis, is a anticoagulant for the treatment of venous thromboembolic events. It is taken by mouth. It is a direct factor Xa inhibitor.Apixaban was approved in Europe in 2012. It was approved in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is being developed in a joint venture by Pfizer and Bristol-Myers Squibb.".
- Q414462 label "Apixaban".
- Q414462 depiction Apixaban.svg.